Literature DB >> 9089390

Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine.

T Nakanishi1, K Kadomatsu, T Okamoto, K Ichihara-Tanaka, T Kojima, H Saito, Y Tomoda, T Muramatsu.   

Abstract

Midkine (MK) is a 13-kDa heparin-binding growth/differentiation factor, and its interaction with heparan sulfate proteoglycan is important in promotion of neurite outgrowth. This study was performed to reveal the species of syndecans that interact with MK during embryogenesis of the central nervous system in the rat. Northern blot analysis and immunohistochemical staining using antibodies to syndecans showed that syndecan-1 was strongly expressed in the brain and spinal cord of the 10-day rat fetus, and the expression became weak as embryogenesis proceeded. On the other hand, syndecan-3 expression was stronger both in the brain and spinal cord in the later developmental period (day 14-16 of gestation). No significant expression of ryudocan (syndecan-4) was detected in fetal brains by Northern blot analysis. Syndecan-3 isolated from 16-day rat fetus bound to MK strongly, as did syndecan-1 isolated from 10-day rat fetus. Thus, both syndecan-1 and syndecan-3 were considered to be involved in interaction with MK during construction of the central nervous system; syndecan-1 is expected to play important roles in the earlier periods, and syndecan-3 in the later periods.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089390

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  33 in total

1.  The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.

Authors:  Sivan Cohen; Or-yam Shoshana; Einat Zelman-Toister; Nitsan Maharshak; Inbal Binsky-Ehrenreich; Maya Gordin; Inbal Hazan-Halevy; Yair Herishanu; Lev Shvidel; Michal Haran; Lin Leng; Richard Bucala; Sheila Harroch; Idit Shachar
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  PAd-shRNA-PTN reduces pleiotrophin of pancreatic cancer cells and inhibits neurite outgrowth of DRG.

Authors:  Jun Yao; Min Zhang; Qing-Yong Ma; Zheng Wang; Lian-Cai Wang; Dong Zhang
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

Review 3.  Midkine as a regulator of B cell survival in health and disease.

Authors:  Sivan Cohen; Idit Shachar
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  Role of midkine-progranulin interaction during angiogenesis of hepatocellular carcinoma.

Authors:  Huilian Huang; Jing Li; Yongliang Lu; Lishan Min; Dongli Li; Licheng Dai
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 5.  Midkine and cytoplasmic maturation of mammalian oocytes in the context of ovarian follicle physiology.

Authors:  Shuntaro Ikeda; Masayasu Yamada
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 6.  Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.

Authors:  G Herradón; C Pérez-García
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 7.  Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function.

Authors:  Anders Malmström; Barbara Bartolini; Martin A Thelin; Benny Pacheco; Marco Maccarana
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

8.  Expression of the heparin-binding growth factors Midkine and pleiotrophin during ocular development.

Authors:  Ruda Cui; Peter Lwigale
Journal:  Gene Expr Patterns       Date:  2019-02-27       Impact factor: 1.224

Review 9.  The role of midkine in skeletal remodelling.

Authors:  A Liedert; T Schinke; A Ignatius; M Amling
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 10.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.